SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹63 Cr | ₹59 Cr | ₹54 Cr | ₹47 Cr | ₹33 Cr |
What is the latest Total Current Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹63 Cr |
| Mar2024 | ₹59 Cr |
| Mar2023 | ₹54 Cr |
| Mar2022 | ₹47 Cr |
| Mar2021 | ₹33 Cr |
How is Total Current Liabilities of SAKAR HEALTHCARE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹63 Cr | 6.99 | |
| Mar2024 | ₹59 Cr | 8.38 | |
| Mar2023 | ₹54 Cr | 16.50 | |
| Mar2022 | ₹47 Cr | 40.60 | |
| Mar2021 | ₹33 Cr | - | |
Compare Total Current Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,074.1 Cr | -0.6% | 13.7% | 71.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | -0.5% | 1.8% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -0.3% | -1.3% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 4.4% | 6% | 27.7% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | 1% | -3% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.1% | 8% | 3.8% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -0.6% |
13.7% |
71.6% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses